BRAT1 and glioblastoma: To investigate the potential effects of BRAT1, stable BRAT1-knockdown (KD) cells were developed using lentiviral shRNA constructs for the GBM cell line U251 [30] and the GSC line NCH644 [31], which represents a sub-population inside of GBM tumors, by expressing various markers associated with stemness [9].